Mitsui & Co., Ltd.("Mitsui", Head Office: Tokyo, President and CEO: Tatsuo Yasunaga) announced that MBK Healthcare Partners Ltd.("MBKHP"), a wholly owned subsidiary of Mitsui , has sold 164.6million shares (approx.2% of issued shares) of IHH Healthcare Berhad("IHH") on Sep. 27th, 2016. Through this transaction MBKHP's interest in IHH has decreased from 20.1% to 18.1%.
(1) MBKHP (Mitsui's subsidiary)
|Company name||MBK Healthcare Partners Limited|
|Main Business||Investment in IHH|
|Shareholders and ownership||Mitsui 100%|
|Company name||IHH Healthcare Berhad|
|Main Business||Healthcare-related business throughout Asia and Central & Eastern Europe, the Middle East and North Africa("CEEMENA") region, including hospital operation and contact management, operation of medical education institutions.|
|Shareholders and ownership||MBKHP 18.1%, Others 81.9%|
This announcement contains forward-looking statements. These forward-looking statements are based on Mitsui's current assumptions, expectations and beliefs in light of the information currently possessed by it and involve known and unknown risks, uncertainties and other factors. Such risks, uncertainties and other factors may cause Mitsui's actual results, financial position or cash flows to be materially different from any future results, financial position or cash flows expressed or implied by these forward-looking statements. These risks, uncertainties and other factors referred to above include, but are not limited to, those contained in Mitsui's latest Annual Securities Report and Quarterly Securities Report, and Mitsui undertakes no obligation to publicly update or revise any forward-looking statements.
This announcement is published in order to publicly announce specific facts stated above, and does not constitute a solicitation of investments or any similar act inside or outside of Japan, regarding the shares, bonds or other securities issued by us.